Status:
COMPLETED
Rehabilitation for People With COVID-19 in ICU
Lead Sponsor:
University of Padova
Collaborating Sponsors:
Prof. S Masiero, University of Padova, Italy
Dr. A. Venturin, General Hosipital, Padova, Italy
Conditions:
Corona Virus Disease 19 (COVID-19)
COVID
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19 DISEASE Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, severe acute respiratory syndrome from COVID-19, that was first recognized...
Detailed Description
People that develop ARDS due to COVID-19 and requiring admission to ICU (both invasive and non-invasive mechanical ventilation) will be enrolled. Two tertiary referral centers, part of the same region...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 diagnosis, admitted to ICU with ARDS
Exclusion
- Neuromuscular disease, severe heart failure (class IV), persistent severe hypotension (systolic BP \< 90mmHg), disorder of consciousness (DoC)
Key Trial Info
Start Date :
February 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04381338
Start Date
February 28 2020
End Date
December 31 2020
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Teaching Hospital, University of Padova
Padua, Italy
2
Teaching Hospital, University of Verona
Verona, Italy, 37126